Daniel E. Owens - Aug 1, 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Human Resources Officer
Signature
Lisa Taylor as Attorney-in-fact for Dan Owens
Stock symbol
TMCI
Transactions as of
Aug 1, 2022
Transactions value $
-$9,862
Form type
4
Date filed
8/3/2022, 07:00 AM
Previous filing
Jul 6, 2022
Next filing
Aug 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Options Exercise $7.03K +1K +9.35% $7.03 11.7K Aug 1, 2022 Direct F1
transaction TMCI Common Stock Sale -$16.9K -1K -8.55% $16.89 10.7K Aug 1, 2022 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option Right to Buy Options Exercise $0 -1K -0.51% $0.00 197K Aug 1, 2022 Common Stock 1K $7.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 6,700 RSUs.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.58 to $17.04 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025.